BioLife Solutions

BLFS56

$26.01arrow_drop_up2.59%$0.66

BLFS56

$26.01

arrow_drop_up2.59%$0.66

Performance History

Key Stats
Open	$25.73
Prev. Close	$25.39
EPS	-1.11
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	24.26	27.28
52 Week Range	8.92	28.73

Ratios







EPS	-1.11

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About BioLife Solutions (BLFS)

BioLife Solutions Inc (BLFS) is a biotechnology company that provides solutions for cell and gene therapy. The company offers a range of products and services that are designed to support the development and commercialization of cell-based therapies. With a focus on preserving and enhancing the quality of cells, BioLife Solutions has become a trusted partner for leading biotech and pharmaceutical companies.

As of the latest stock price history, BioLife Solutions Inc (BLFS) has had a steady increase in stock price over the years. The company's stock has shown resilience and has outperformed the overall market. With a market cap of over $1 billion, BioLife Solutions has become a key player in the biotech industry.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Michael P. Rice
Headquarters: Bothell
Employees: 466
Exchange: NASDAQ

Keep an eye on BioLife Solutions

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is BioLife Solutions 's (BLFS) price per share?

The current price per share for BioLife Solutions (BLFS) is $26.01. The stock has seen a price change of $0.66 recently, indicating a 2.6% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for BioLife Solutions (BLFS)?

For BioLife Solutions (BLFS), the 52-week high is $28.73, which is 10.48% from the current price. The 52-week low is $8.92, the current price is 191.59% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is BioLife Solutions (BLFS) a growth stock?

BioLife Solutions (BLFS) has shown an average price growth of -4.13% over the past three years. It has received a score of 45 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BioLife Solutions as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is BioLife Solutions (BLFS) stock price performance year to date (YTD)?

As of the latest data, BioLife Solutions (BLFS) has a year-to-date price change of 62.77%. Over the past month, the stock has experienced a price change of 18.55%. Over the last three months, the change has been 2.81%. Over the past six months, the figure is 23.33%. Looking at a longer horizon, the five-year price change stands at 56.22%.

help

Is BioLife Solutions (BLFS) a profitable company?

BioLife Solutions (BLFS) has a net income of -$66.43M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 32.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -5.1% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $143.27M, although specific revenue growth data is currently not available. The gross profit is $46.75M. Operating income is noted at -$70.82M. Furthermore, the EBITDA is -$28M.

help

What is the market capitalization of BioLife Solutions (BLFS)?

BioLife Solutions (BLFS) has a market capitalization of $1.21B. The average daily trading volume is 25.72, indicating the stock's liquidity and investor engagement.